Viewing Study NCT03454503


Ignite Creation Date: 2025-12-24 @ 7:24 PM
Ignite Modification Date: 2025-12-25 @ 5:04 PM
Study NCT ID: NCT03454503
Status: COMPLETED
Last Update Posted: 2021-02-23
First Post: 2018-02-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt
Sponsor: Hikma Pharmaceuticals LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module